---
title: "Hikma: Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) 100 mL — FDA announcement Jul 22, 2024 | Is It on Recall"
description: "Potential presence of Dexmedetomidine HCL Injection (400mcg/100mL) inside the overwrap that is labelled Acetaminophen Injection, 1000mg/100mL, (10mg/mL)."
url: https://isitonrecall.com/recall/fdapress-ce51da04d2c9c57b-hikma-acetaminophen-injection-1-000-mg-per-100-ml-10-mg-ml-100-ml/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Hikma: Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) 100 mL — FDA announcement Jul 22, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jul 22, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) 100 mL
- **Reason**: Potential presence of Dexmedetomidine HCL Injection (400mcg/100mL) inside the overwrap that is labelled Acetaminophen Injection, 1000mg/100mL, (10mg/mL).
- **Classification**: Not supplied
- **Recalling firm**: Hikma Pharmaceuticals PLC
- **Quantity**: Not supplied
- **Agency-reported status**: Company recall announcement
- **Source record identifier**: ce51da04d2c9c57b

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | FOR IMMEDIATE RELEASE - London, July 22, 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA, Inc. is extending its voluntary recall of one lot (listed below) of Acetaminophen Injection, 1000mg/100mL, (10mg/mL) to the consumer/user level. The product is being recalled due to the potential presence of a bag labelled Dexmedetomidine HCL Injection (400mcg/100mL) inside the overwrap that is labelled Acetaminophen Injection, 1000mg/100mL, (10mg/mL).; On July 8, 2024, Hikma voluntarily initiated a retail level recall of Acetaminophen Injection 1000mg/100mL(10mg/mL), lot 24070381.; The lot being recalled was manufactured on 3/19/2024.; The affected lot number and expiration date being recalled is as follows:; The product can be identified by name and NDC and lot code, which are clearly stated on the overwrap of the product label, along with Hikma Pharmaceuticals USA Inc. name and address. Images of the labels are included below:; The product was distributed to Hikma’s direct customers nationwide. Hikma notified its direct customers as part of the recall on July 8, 2024, asking them to locate and remove the recalled product from distribution channels and return the recalled lot to Hikma’s recall service provider (Inmar Rx Solutions Inc.). Hikma also requested the direct customers to notify their direct retail customers to whom this affected product lot was distributed. Hikma is now extending the recall to the consumer/user level and asking customers at medical level facilities to locate and remove the recalled product from their channels and return the recalled lot.; This product lot recall is being made with the FDA’s knowledge.; NDC: \| Product Name and Strength \| Size \| Lot Number \| Expiration Date; 0143-9386-10 0143-9386-01, Individual bag overwrap \| Hikma brand Acetaminophen Injection USP, 1,000 mg per 100 mL (10 mg/mL) \| 100mL bag \| 24070381 \| Sep-2025; Hikma Contact: \| Contact Information \| Areas of Support; Hikma Pharmaceuticals USA Inc, – Customer Service \| (P): (800) 631-2174 (E): usrecall@hikma.com (F): (732) 542-0940 Hours of operation, M-F: 8:00am-6pm (EST) \| Recall related inquires; Inmar Rx Solutions, Inc. (Hikma 3rd Party Recall Service Provider) \| Mail to: Inmar RX Solutions, Attention recall Coordinator, 3845 Grand Lakes Way, Grand Prairie, TX 75050 (E): HikmaEvent@Inmar.com (F): 1-817-868-5362 \| Product Returns |

Match all identifying details in the current notice. A brand name alone is not enough.

## Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

**FDA company announcement, table 1**

| NDC: | Product Name and Strength | Size | Lot Number | Expiration Date |
| --- | --- | --- | --- | --- |
| 0143-9386-10 0143-9386-01, Individual bag overwrap | Hikma brand Acetaminophen Injection USP, 1,000 mg per 100 mL (10 mg/mL) | 100mL bag | 24070381 | Sep-2025 |

**FDA company announcement, table 2**

| Hikma Contact: | Contact Information | Areas of Support |
| --- | --- | --- |
| Hikma Pharmaceuticals USA Inc, – Customer Service | (P): (800) 631-2174 (E): usrecall@hikma.com (F): (732) 542-0940 Hours of operation, M-F: 8:00am-6pm (EST) | Recall related inquires |
| Inmar Rx Solutions, Inc. (Hikma 3rd Party Recall Service Provider) | Mail to: Inmar RX Solutions, Attention recall Coordinator, 3845 Grand Lakes Way, Grand Prairie, TX 75050 (E): HikmaEvent@Inmar.com (F): 1-817-868-5362 | Product Returns |

Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection).

## Distribution

The product was distributed to Hikma’s direct customers nationwide. Hikma notified its direct customers as part of the recall on July 8, 2024, asking them to locate and remove the recalled product from distribution channels and return the recalled lot to Hikma’s recall service provider (Inmar Rx Solutions Inc.). Hikma also requested the direct customers to notify their direct retail customers to whom this affected product lot was distributed. Hikma is now extending the recall to the consumer/user level and asking customers at medical level facilities to locate and remove the recalled product from their channels and return the recalled lot.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Alaska](https://isitonrecall.com/state/alaska/)
- [Alabama](https://isitonrecall.com/state/alabama/)
- [Arkansas](https://isitonrecall.com/state/arkansas/)
- [Arizona](https://isitonrecall.com/state/arizona/)
- [California](https://isitonrecall.com/state/california/)
- [Colorado](https://isitonrecall.com/state/colorado/)
- [Connecticut](https://isitonrecall.com/state/connecticut/)
- [Delaware](https://isitonrecall.com/state/delaware/)
- [Florida](https://isitonrecall.com/state/florida/)
- [Georgia](https://isitonrecall.com/state/georgia/)
- [Hawaii](https://isitonrecall.com/state/hawaii/)
- [Iowa](https://isitonrecall.com/state/iowa/)
- [Idaho](https://isitonrecall.com/state/idaho/)
- [Illinois](https://isitonrecall.com/state/illinois/)
- [Indiana](https://isitonrecall.com/state/indiana/)
- [Kansas](https://isitonrecall.com/state/kansas/)
- [Kentucky](https://isitonrecall.com/state/kentucky/)
- [Louisiana](https://isitonrecall.com/state/louisiana/)
- [Massachusetts](https://isitonrecall.com/state/massachusetts/)
- [Maryland](https://isitonrecall.com/state/maryland/)
- [Maine](https://isitonrecall.com/state/maine/)
- [Michigan](https://isitonrecall.com/state/michigan/)
- [Minnesota](https://isitonrecall.com/state/minnesota/)
- [Missouri](https://isitonrecall.com/state/missouri/)
- [Mississippi](https://isitonrecall.com/state/mississippi/)
- [Montana](https://isitonrecall.com/state/montana/)
- [North Carolina](https://isitonrecall.com/state/north-carolina/)
- [North Dakota](https://isitonrecall.com/state/north-dakota/)
- [Nebraska](https://isitonrecall.com/state/nebraska/)
- [New Hampshire](https://isitonrecall.com/state/new-hampshire/)
- [New Jersey](https://isitonrecall.com/state/new-jersey/)
- [New Mexico](https://isitonrecall.com/state/new-mexico/)
- [Nevada](https://isitonrecall.com/state/nevada/)
- [New York](https://isitonrecall.com/state/new-york/)
- [Ohio](https://isitonrecall.com/state/ohio/)
- [Oklahoma](https://isitonrecall.com/state/oklahoma/)
- [Oregon](https://isitonrecall.com/state/oregon/)
- [Pennsylvania](https://isitonrecall.com/state/pennsylvania/)
- [Rhode Island](https://isitonrecall.com/state/rhode-island/)
- [South Carolina](https://isitonrecall.com/state/south-carolina/)
- [South Dakota](https://isitonrecall.com/state/south-dakota/)
- [Tennessee](https://isitonrecall.com/state/tennessee/)
- [Texas](https://isitonrecall.com/state/texas/)
- [Utah](https://isitonrecall.com/state/utah/)
- [Virginia](https://isitonrecall.com/state/virginia/)
- [Vermont](https://isitonrecall.com/state/vermont/)
- [Washington](https://isitonrecall.com/state/washington/)
- [Wisconsin](https://isitonrecall.com/state/wisconsin/)
- [West Virginia](https://isitonrecall.com/state/west-virginia/)
- [Wyoming](https://isitonrecall.com/state/wyoming/)

## Dates in the source

- **Fda listing date**: Jul 22, 2024
- **Company announcement date**: Jul 22, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers with questions regarding this recall can contact Inmar by telephone at 877-890- 0765 (Monday through Friday, 9 a.m. to 5 p.m. ET) or by email at rxrecalls@inmar.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Acetaminophen records](https://isitonrecall.com/drug/acetaminophen/) [Medications records](https://isitonrecall.com/category/medications/) [Hikma Pharmaceuticals PLC records](https://isitonrecall.com/brand/hikma-pharmaceuticals-plc/)